| | | | | |
CRAI CRA International, Inc. | €143,77 | +2,58% | €879,73M | €112,39K | |
HBNC Horizon Bancorp, Inc. Common Stock | €17,1169 | -0,05% | €879,30M | €508,58K | |
AIAI AIAI Holdings Corporation Class A Common Stock | €2,9784 | +2,38% | €878,46M | €251,74K | |
LUXE LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share | €6,4416 | +0,68% | €878,23M | €67,51K | |
ABUS Arbutus Biopharma Corporation Common Stock | €4,4329 | +0,00% | €878,18M | €3,29M | |
ALVO Alvotech Ordinary Shares | €4,3723 | -4,54% | €878,05M | €583,71K | |
| €10,0043 | +1,45% | €877,28M | €1,26M | |
AMPH Amphastar Pharmaceuticals, Inc. | €20,7099 | +0,59% | €875,80M | €411,13K | |
PCRX Pacira BioSciences, Inc. Common Stock | €21,3679 | -2,68% | €875,23M | €362,88K | |
CHY Calamos Convertible and High Income Fund | €10,5801 | -2,71% | €874,69M | €187,31K | |
NWPX NWPX Infrastructure, Inc. Common Stock | €87,0216 | -3,95% | €873,10M | €112,80K | |
TTI TETRA Technologies, Inc. | €5,6450 | -4,26% | €873,05M | €1,90M | |
OBX Obsidian Therapeutics, Inc. Common Stock | €15,6537 | +1,57% | €871,77M | €394,33K | |
SBGI Sinclair, Inc. Class A Common Stock | €12,4502 | +3,45% | €870,32M | €391,56K | |
| €5,5584 | -1,68% | €868,74M | €2,51M | |
